Carla Casulo
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 82
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 40
- Oncology top 2%
- Viral-associated cancers and disorders 28
- CAR-T cell therapy research 16
- Cancer Immunotherapy and Biomarkers 6
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 9
- Immunology top 10%
-
- CNS Lymphoma Diagnosis and Treatment 16
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Jonathan W. FriedbergAndrew D. ZelenetzJocelyn MaraguliaRichard BurackChristopher R. FlowersJames R. CerhanBrian K. LinkXiaolei Zhou
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Carla Casulo
90 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Pathology and Forensic Medicine 1.3k
- Genetics 555
- Oncology 1.1k
- Reproductive Medicine 178
- Immunology 400
Countries citing papers authored by Carla Casulo
This map shows the geographic impact of Carla Casulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Casulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Casulo more than expected).
Fields of papers citing papers by Carla Casulo
This network shows the impact of papers produced by Carla Casulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Casulo. The network helps show where Carla Casulo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carla Casulo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 29 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 1 | |
| 15 | 2019 | 8 | |
| 16 | 2018 | 18 | |
| 17 | 2017 | 1 | |
| 18 | 2016 | 9 | |
| 19 | 2016 | 6 | |
| 20 | Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Studybreakdown → | 2015 | 509 |
About Carla Casulo
Carla Casulo is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 95 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (82 papers), Chronic Lymphocytic Leukemia Research (40 papers), Viral-associated cancers and disorders (28 papers), CNS Lymphoma Diagnosis and Treatment (16 papers), CAR-T cell therapy research (16 papers), Ovarian cancer diagnosis and treatment (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.3k citations), Genetics (555 citations) and Oncology (1.1k citations). Carla Casulo has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Jonathan W. Friedberg, Andrew D. Zelenetz, Jocelyn Maragulia, Richard Burack, Christopher R. Flowers, James R. Cerhan, Brian K. Link, Xiaolei Zhou, Keith Dawson and John D. Hainsworth. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Blood Advances and Best Practice & Research Clinical Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.